Today: June 23, 2018, 6:37 am
  
Business

Novodiag® Launch, a New Diagnostic Solution for Infectious Diseases

PR-Inside.com: 2018-01-03 08:02:01

Novodiag® Launch, a New Diagnostic Solution for Infectious Diseases

Mobidiag
Dorothee Allard, + 33(0)1 55 25 17 13
dorothee.allard@mobidiag.com

Mobidiag, a Finnish molecular diagnostics company, launches Novodiag®, a fully automated solution for syndromic and targeted testing of infectious diseases, supporting limitation of antibiotic use.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201801020055

 Tuomas Tenkanen (Mobidiag CEO) and the fully automated Novodiag® system (Photo: Mobidiag)

Tuomas Tenkanen (Mobidiag CEO) and the fully automated Novodiag® system (Photo: Mobidiag)

The end of 2017 has been marked by a key event for Mobidiag, the launch of the Novodiag® solution at the Finnish Embassy in Paris (France) with the support of M. Ambroise Fayolle, VP of the EIB (European Investment Bank) and Dr. Etienne Ruppé, MCU-PH/Associate Professor, bacteriology department at Bichat hospital (Paris, France).

The new Novodiag® solution allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results within a few hours. In a time where antibiotic resistance is a major threat for global health, the optimized process offered by Novodiag allows, among other things, to detect antibiotic resistance and limit the systematic use of antibiotics. This instrument allows detection of infectious diseases in a few hours and supports infection management accordingly.

This molecular diagnostic solution offers an easy to use and cost-efficient method, with very limited hands-on-time and without the need for much technical expertise. Novodiag is particularly suitable for low volumes and on demand testing for clinical laboratories.

Novodiag brings the power of molecular diagnostics into routine use for on-demand targeted and syndromic testing, a combination unachieved by other providers says Tuomas Tenkanen, CEO at Mobidiag.

One of our cartridges can also identify dozens of targets, including the majority of bacteria that cause diarrhea, for instance. With quick and reliable results, our fully automated system can support early decision making prior to any treatment delivery and also improve patient care by reducing for example the unnecessary use of antibiotics, a key focus in our product pipeline explains Tuomas Tenkanen.

Zoom on Mobidiag, a committed player in the fight against antibiotic resistance.
Mobidiag takes action in infectious disease diagnostics, including antibiotic resistances. There are between twenty five to thirty antibiotic resistant genes. Our solution can, with one single sample, detect large panel of targets. We can then avoid spreading of these resistances in hospital settings, sates Yann Marcy, Director of Mobidiag France.

Learn more about Novodiag.

About Mobidiag Ltd.
Established in 2000, Mobidiag develops and commercializes innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008. Mobidiag is headquartered in Espoo, Finland, with an R&D center in France and subsidiaries in UK and Sweden.
Combining Amplidiag and Novodiag solutions, Mobidiag offers a comprehensive line of products for fast, reliable and cost-efficient diagnostics. Mobidiag is then able to cover all laboratories requirements no matter their size, throughput and centralized/decentralized organization.

To learn more, visit www.mobidiag.com.

Press Information


Published by
Hossam Abdel-Kader
+43 1 9582319
e-mail
www.pr-inside.com/



# 629 Words
Related Articles
More From The Author
ARCADIS CHIEF FINANCIAL OFFICER RESIGNS
Amsterdam, 3 Jan 2018 - Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy firm for natural and built assets, today [..]
LayerStack Launched the Fourth Datacenter in Japan [..]
LayerStack, an Infrastructure-as-a-Service (IaaS) provider, today announced an expansion in Japan with the launching of its [..]
Car Sharing Goes Up a Gear in [..]
As private car ownership continues to drop in London, car sharing is taking off LONDON, Jan. 03, 2018 (GLOBE NEWSWIRE) [..]
HARLEY-DAVIDSON TO REPORT FOURTH QUARTER RESULTS ON [..]
  Webcast Conference Call Scheduled for 8 a.m. CST  MILWAUKEE, Jan. 1, 2018 - Harley-Davidson, Inc. (NYSE:HOG) will release [..]
Glenbriar Technologies Mgmt. confirm no material changes
CALGARY, Alberta, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Glenbriar Technologies Inc. (CSE:GTI) At the request of the IIROC, Glenbriar [..]
 
More From Business
Carrie Lam encourages French companies to leverage [..]
HONG KONG, June 20, 2018 - (ACN Newswire) - The Chief Executive of the Hong Kong Special Administrative Region, Mrs [..]
Tarps Now® Expansion Focuses on Deliveries of [..]
ST. JOSEPH, MICHIGAN, UNITED STATES -- Tarps Now® is pleased to announce increased commitment to Heavy Duty Tarps and Covers [..]
Hong Kong Q2 2018 Exports Index at [..]
HONG KONG, June 20, 2018 - (ACN Newswire) - The HKTDC Export Index for the second quarter of 2018 (2Q18) [..]
Colorado Springs Movers Celebrates 21 Years Serving [..]
Moving Day Inc. is a Colorado Springs based moving company that is celebrating 21 years of serving clients by providing [..]
Apple Pay Coming to JCB's Customers in [..]
TOKYO, June 19, 2018 - (ACN Newswire) - JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd, [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.